APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urokinase

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Selected research

Market Outlook & Growth Opportunities

Global Urokinase Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchUrokinase Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Urokinase Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Urokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urokinase Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Urokinase Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Global Urokinase (CAS 9039-53-6) main manufactuers include Syner-Med, LIVZON, Wanhua Biochem and Techpool, totally accounting for about 50% of the market. China is the largest market of Urokinase (CAS 9039-53-6), holding a share about 56%. As for the types of products, it can be divided into urokinase powder and urokinase polution. The most common type is urokinase powder, with a share about 92%. As for the applications of products, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share about 78%.

This report provides an overview of the global Urokinase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Urokinase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Urokinase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Urokinase market size, projected growth trends, production technologies, key applications, and end-use industries.

Urokinase Segment by Company

Syner-Med

Wanhua Biochem

Jiangxi Haoran Bio-Pharma

Jiangsu Aidea Pharmaceutical

Techpool

Microbic Biosystems

LIVZON

Urokinase Segment by Type

Urokinase Powder

Urokinase Solution

Urokinase Segment by Application

Hospital

Clinic

Others

Urokinase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Urokinase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Urokinase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Urokinase significant trends, drivers, influence factors in global and regions.

6. To analyze Urokinase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urokinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Urokinase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urokinase industry.

Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Urokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Urokinase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Urokinase Industry Trends Table 2. Urokinase Industry Drivers Table 3. Urokinase Industry Opportunities and Challenges Table 4. Urokinase Industry Restraints Table 5. Global Urokinase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Urokinase Revenue Share by Company (2021-2026) Table 7. Global Urokinase Sales Volume by Company (BIU) & (2021-2026) Table 8. Global Urokinase Sales Volume Share by Company (2021-2026) Table 9. Global Urokinase Average Price (US$/MIU) of Company (2021-2026) Table 10. Global Urokinase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Urokinase Key Company Manufacturing Base & Headquarters Table 12. Global Urokinase Company, Product Type & Application Table 13. Global Urokinase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Urokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Urokinase Powder Table 18. Significant Companies of Urokinase Solution Table 19. Global Urokinase Sales Volume by Type 2021 VS 2025 VS 2032 (BIU) Table 20. Global Urokinase Sales Volume by Type (2021-2026) & (BIU) Table 21. Global Urokinase Sales Volume by Type (2027-2032) & (BIU) Table 22. Global Urokinase Sales Volume Share by Type (2021-2026) Table 23. Global Urokinase Sales Volume Share by Type (2027-2032) Table 24. Global Urokinase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Urokinase Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Urokinase Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Urokinase Sales Value Share by Type (2021-2026) Table 28. Global Urokinase Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Urokinase Sales Volume by Application 2021 VS 2025 VS 2032 (BIU) Table 33. Global Urokinase Sales Volume by Application (2021-2026) & (BIU) Table 34. Global Urokinase Sales Volume by Application (2027-2032) & (BIU) Table 35. Global Urokinase Sales Volume Share by Application (2021-2026) Table 36. Global Urokinase Sales Volume Share by Application (2027-2032) Table 37. Global Urokinase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Urokinase Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Urokinase Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Urokinase Sales Value Share by Application (2021-2026) Table 41. Global Urokinase Sales Value Share by Application (2027-2032) Table 42. Global Urokinase Sales by Region: 2021 VS 2025 VS 2032 (BIU) Table 43. Global Urokinase Sales by Region (2021-2026) & (BIU) Table 44. Global Urokinase Sales Market Share by Region (2021-2026) Table 45. Global Urokinase Sales by Region (2027-2032) & (BIU) Table 46. Global Urokinase Sales Market Share by Region (2027-2032) Table 47. Global Urokinase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Urokinase Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Urokinase Sales Value Share by Region (2021-2026) Table 50. Global Urokinase Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Urokinase Sales Value Share by Region (2027-2032) Table 52. Global Urokinase Market Average Price (US$/MIU) by Region (2021-2026) Table 53. Global Urokinase Market Average Price (US$/MIU) by Region (2027-2032) Table 54. Global Urokinase Sales by Country: 2021 VS 2025 VS 2032 (BIU) Table 55. Global Urokinase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Urokinase Sales by Country (2021-2026) & (BIU) Table 57. Global Urokinase Sales Market Share by Country (2021-2026) Table 58. Global Urokinase Sales by Country (2027-2032) & (BIU) Table 59. Global Urokinase Sales Market Share by Country (2027-2032) Table 60. Global Urokinase Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Urokinase Sales Value Market Share by Country (2021-2026) Table 62. Global Urokinase Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Urokinase Sales Value Market Share by Country (2027-2032) Table 64. Syner-Med Company Information Table 65. Syner-Med Business Overview Table 66. Syner-Med Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 67. Syner-Med Urokinase Product Portfolio Table 68. Syner-Med Recent Development Table 69. Wanhua Biochem Company Information Table 70. Wanhua Biochem Business Overview Table 71. Wanhua Biochem Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 72. Wanhua Biochem Urokinase Product Portfolio Table 73. Wanhua Biochem Recent Development Table 74. Jiangxi Haoran Bio-Pharma Company Information Table 75. Jiangxi Haoran Bio-Pharma Business Overview Table 76. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 77. Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio Table 78. Jiangxi Haoran Bio-Pharma Recent Development Table 79. Jiangsu Aidea Pharmaceutical Company Information Table 80. Jiangsu Aidea Pharmaceutical Business Overview Table 81. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 82. Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio Table 83. Jiangsu Aidea Pharmaceutical Recent Development Table 84. Techpool Company Information Table 85. Techpool Business Overview Table 86. Techpool Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 87. Techpool Urokinase Product Portfolio Table 88. Techpool Recent Development Table 89. Microbic Biosystems Company Information Table 90. Microbic Biosystems Business Overview Table 91. Microbic Biosystems Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 92. Microbic Biosystems Urokinase Product Portfolio Table 93. Microbic Biosystems Recent Development Table 94. LIVZON Company Information Table 95. LIVZON Business Overview Table 96. LIVZON Urokinase Sales (BIU), Value (US$ Million), Price (US$/MIU) and Gross Margin (2021-2026) Table 97. LIVZON Urokinase Product Portfolio Table 98. LIVZON Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Urokinase Distributors List Table 102. Urokinase Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Urokinase Product Image Figure 2. Global Urokinase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urokinase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Urokinase Sales (2021-2032) & (BIU) Figure 5. Global Urokinase Sales Average Price (US$/MIU) & (2021-2032) Figure 6. Global Urokinase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Urokinase Powder Image Figure 10. Urokinase Solution Image Figure 11. Global Urokinase Sales Volume by Type (2021 VS 2025 VS 2032) & (BIU) Figure 12. Global Urokinase Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Urokinase Sales Volume Share by Type (2021-2032) Figure 14. Global Urokinase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Urokinase Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Urokinase Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Urokinase Sales Volume by Application (2021 VS 2025 VS 2032) & (BIU) Figure 21. Global Urokinase Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Urokinase Sales Volume Share by Application (2021-2032) Figure 23. Global Urokinase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Urokinase Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Urokinase Sales Value Share by Application (2021-2032) Figure 26. Global Urokinase Sales by Region: 2021 VS 2025 VS 2032 (BIU) Figure 27. Global Urokinase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Urokinase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Urokinase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Urokinase Sales Value (2021-2032) & (US$ Million) Figure 31. North America Urokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Urokinase Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Urokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Urokinase Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Urokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Urokinase Sales Value (2021-2032) & (US$ Million) Figure 37. South America Urokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Urokinase Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Urokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Urokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Urokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Urokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Urokinase Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Urokinase Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Urokinase Powder
  • Urokinase Solution
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Syner-Med
  • Wanhua Biochem
  • Jiangxi Haoran Bio-Pharma
  • Jiangsu Aidea Pharmaceutical
  • Techpool
  • Microbic Biosystems
  • LIVZON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urokinase Sales Value (2021-2032)
  4. 1.2.2 Global Urokinase Sales Volume (2021-2032)
  5. 1.2.3 Global Urokinase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Urokinase Market Dynamics
  1. 2.1 Urokinase Industry Trends
  2. 2.2 Urokinase Industry Drivers
  3. 2.3 Urokinase Industry Opportunities and Challenges
  4. 2.4 Urokinase Industry Restraints
3 Urokinase Market by Company
  1. 3.1 Global Urokinase Company Revenue Ranking in 2025
  2. 3.2 Global Urokinase Revenue by Company (2021-2026)
  3. 3.3 Global Urokinase Sales Volume by Company (2021-2026)
  4. 3.4 Global Urokinase Average Price by Company (2021-2026)
  5. 3.5 Global Urokinase Company Ranking (2024-2026)
  6. 3.6 Global Urokinase Company Manufacturing Base and Headquarters
  7. 3.7 Global Urokinase Company Product Type and Application
  8. 3.8 Global Urokinase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Urokinase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Urokinase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Urokinase Market by Type
  1. 4.1 Urokinase Type Introduction
  2. 4.1.1 Urokinase Powder
  3. 4.1.2 Urokinase Solution
  4. 4.2 Global Urokinase Sales Volume by Type
  5. 4.2.1 Global Urokinase Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Urokinase Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Urokinase Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Urokinase Sales Value by Type
  9. 4.3.1 Global Urokinase Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Urokinase Sales Value by Type (2021-2032)
  11. 4.3.3 Global Urokinase Sales Value Share by Type (2021-2032)
5 Urokinase Market by Application
  1. 5.1 Urokinase Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Urokinase Sales Volume by Application
  6. 5.2.1 Global Urokinase Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urokinase Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Urokinase Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Urokinase Sales Value by Application
  10. 5.3.1 Global Urokinase Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Urokinase Sales Value by Application (2021-2032)
  12. 5.3.3 Global Urokinase Sales Value Share by Application (2021-2032)
6 Urokinase Regional Sales and Value Analysis
  1. 6.1 Global Urokinase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Urokinase Sales by Region (2021-2032)
  3. 6.2.1 Global Urokinase Sales by Region: 2021-2026
  4. 6.2.2 Global Urokinase Sales by Region (2027-2032)
  5. 6.3 Global Urokinase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Urokinase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Urokinase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Urokinase Sales Value by Region (2027-2032)
  9. 6.5 Global Urokinase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Urokinase Sales Value (2021-2032)
  12. 6.6.2 North America Urokinase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Urokinase Sales Value (2021-2032)
  15. 6.7.2 Europe Urokinase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Urokinase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Urokinase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Urokinase Sales Value (2021-2032)
  21. 6.9.2 South America Urokinase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Urokinase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Urokinase Sales Value Share by Country, 2025 VS 2032
7 Urokinase Country-level Sales and Value Analysis
  1. 7.1 Global Urokinase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Urokinase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Urokinase Sales by Country (2021-2032)
  4. 7.3.1 Global Urokinase Sales by Country (2021-2026)
  5. 7.3.2 Global Urokinase Sales by Country (2027-2032)
  6. 7.4 Global Urokinase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Urokinase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Urokinase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Urokinase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Urokinase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Urokinase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Urokinase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Urokinase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Urokinase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Urokinase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Urokinase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Urokinase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Urokinase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Urokinase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Urokinase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Urokinase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Urokinase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Urokinase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Urokinase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Urokinase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Urokinase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Urokinase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Urokinase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Urokinase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Urokinase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Urokinase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Urokinase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Urokinase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Urokinase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Urokinase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Urokinase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Urokinase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Urokinase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Urokinase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Urokinase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Urokinase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Urokinase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Urokinase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Urokinase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Urokinase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Urokinase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Urokinase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Urokinase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Urokinase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Urokinase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Urokinase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Urokinase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Urokinase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Urokinase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Urokinase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Urokinase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Urokinase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Urokinase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Urokinase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Urokinase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Urokinase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Urokinase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Urokinase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Urokinase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Urokinase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Urokinase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Urokinase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Urokinase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Urokinase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Urokinase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Urokinase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Urokinase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Urokinase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Urokinase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Urokinase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Urokinase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Urokinase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Urokinase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Urokinase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Urokinase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Urokinase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Urokinase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Urokinase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Urokinase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Urokinase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Urokinase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Urokinase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Urokinase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Urokinase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Urokinase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Urokinase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Urokinase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Syner-Med
  2. 8.1.1 Syner-Med Company Information
  3. 8.1.2 Syner-Med Business Overview
  4. 8.1.3 Syner-Med Urokinase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Syner-Med Urokinase Product Portfolio
  6. 8.1.5 Syner-Med Recent Developments
  7. 8.2 Wanhua Biochem
  8. 8.2.1 Wanhua Biochem Company Information
  9. 8.2.2 Wanhua Biochem Business Overview
  10. 8.2.3 Wanhua Biochem Urokinase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Wanhua Biochem Urokinase Product Portfolio
  12. 8.2.5 Wanhua Biochem Recent Developments
  13. 8.3 Jiangxi Haoran Bio-Pharma
  14. 8.3.1 Jiangxi Haoran Bio-Pharma Company Information
  15. 8.3.2 Jiangxi Haoran Bio-Pharma Business Overview
  16. 8.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio
  18. 8.3.5 Jiangxi Haoran Bio-Pharma Recent Developments
  19. 8.4 Jiangsu Aidea Pharmaceutical
  20. 8.4.1 Jiangsu Aidea Pharmaceutical Company Information
  21. 8.4.2 Jiangsu Aidea Pharmaceutical Business Overview
  22. 8.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio
  24. 8.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
  25. 8.5 Techpool
  26. 8.5.1 Techpool Company Information
  27. 8.5.2 Techpool Business Overview
  28. 8.5.3 Techpool Urokinase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Techpool Urokinase Product Portfolio
  30. 8.5.5 Techpool Recent Developments
  31. 8.6 Microbic Biosystems
  32. 8.6.1 Microbic Biosystems Company Information
  33. 8.6.2 Microbic Biosystems Business Overview
  34. 8.6.3 Microbic Biosystems Urokinase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Microbic Biosystems Urokinase Product Portfolio
  36. 8.6.5 Microbic Biosystems Recent Developments
  37. 8.7 LIVZON
  38. 8.7.1 LIVZON Company Information
  39. 8.7.2 LIVZON Business Overview
  40. 8.7.3 LIVZON Urokinase Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LIVZON Urokinase Product Portfolio
  42. 8.7.5 LIVZON Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Urokinase Value Chain Analysis
  2. 9.1.1 Urokinase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Urokinase Sales Mode & Process
  6. 9.2 Urokinase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Urokinase Distributors
  9. 9.2.3 Urokinase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst